Dr. Aguayo-Hiraldo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4650 Sunset blvd
MS54
Los Angeles, CA 90027Phone+1 323-361-4755- Is this information wrong?
Summary
- I am currently the medical director for the Transplant and Cellular Therapy section of the Cancer and Blood Disorders Institute at CHLA. My clinical interest includes stem cell transplants for non-malignant disorders, specifically immune deficiencies or disorders of immune dysregulation. My research focused on equitable access to cellular therapy and prevention/treatment of GVHD & TMA.
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2013 - 2016
- University of South Florida MorsaniResidency, Internal Medicine/Pediatrics, 2009 - 2013
- San Juan Bautista School of MedicineClass of 2009, MD, Cum Laude
Certifications & Licensure
- CA State Medical License 2018 - 2025
- TX State Medical License 2016 - 2020
- NM State Medical License 2013 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II intervent...Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, Paibel Aguayo-Hiraldo, Christopher C Dvorak, Michael R Verneris, Donald B Kohn, Sung-Yun Pai, Blachy J Dávila Saldaña...> ;Nature Communications. 2024 Apr 18
- 1 citationsA Day 14 Endpoint for Acute GVHD Clinical Trials.Al Malki, M. M., Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo-Hiraldo, Monzr M Al Malki, Francis Ayuk, Peter Bader, Ja...> ;Transplantation and Cellular Therapy. 2024 Apr 1
- A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.Kapoor, U., Muna Qayed, Urvi Kapoor, Scott Gillespie, Adrianna Westbrook, Paibel Aguayo-Hiraldo, Francis A Ayuk, Mina Aziz, Janna Baez, Hannah Choe, Zachariah DeFilipp...> ;Transplantation and Cellular Therapy. 2024 Mar 27
- Join now to see all
Press Mentions
- 5 Reasons It’s Important for People of Color to Take Part in Clinical TrialsSeptember 30th, 2023
Professional Memberships
- Member
- Member
- Member
- American Society for Blood and marrow Transplantation-ASBMTMember
- American Society Pediatric Hematology and Oncology- ASPHOMember
Other Languages
- Spanish
Hospital Affiliations
- Children's Hospital Los AngelesLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: